Valeant Pharmaceuticals North America

Valeant Pharmaceuticals North America was a Canadian multinational pharmaceutical company founded in 2010 and headquartered in Quebec, Canada. The company specialized in developing, manufacturing and marketing a wide variety of prescription and generic medicines, as well as over-the-counter remedies, medical devices and a number of consumer health products. Valeant Pharmaceuticals North America was known for its innovative pharmaceutical research and development, as well as its streamlined business model, which allowed for more efficient drug production and delivery to patients.

However, the company was also criticized for its various controversial business practices, which included price gouging, aggressive marketing, and allegations of accounting fraud. In 2015, Valeant Pharmaceuticals North America came under heavy scrutiny from investors and regulators, leading to a sharp decline in the company's stock price and eventually culminating in its bankruptcy in 2019. Today, Valeant Pharmaceuticals North America no longer exists as a business entity, though its legacy and impact on the pharmaceutical industry still remain.